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Background: Species of the genus Pediococcus are known to produce antimicrobial peptides such as pediocin-like
bacteriocins that contain YGNGVXC as a conserved motif at their N-terminus. Until now, the molecular weight of
various bacteriocins produced by different strains of the genus Pediococcus have been found to vary between 2.7
to 4.6 kD. In the present study, we characterized an antimicrobial peptide produced by P. pentosaceus strain IE-3.
Results: Antimicrobial peptide was isolated and purified from the supernatant of P. pentosaceus strain IE-3 grown
for 48 h using cation exchange chromatography and reversed-phase high-performance liquid chromatography
(RP-HPLC) techniques. While MALDI-TOF MS experiments determined the precise molecular mass of the peptide to
be 1701.00 Da, the de novo sequence (APVPFSCTRGCLTHLV) of the peptide revealed no similarity with reported
pediocins and did not contain the YGNGVXC conserved motif. Unlike pediocin-like bacteriocins, the low molecular
weight peptide (LMW) showed resistance to different proteases. Moreover, peptide treated with reducing agent
like dithiothreitol (DTT) exhibited increased activity against both Gram-positive and Gram-negative test strains in
comparison to native peptide. However, peptide treated with oxidizing agent such as hydrogen peroxide (H2O2)
did not show any antimicrobial activity.
Conclusion: To our knowledge this is the lowest molecular weight peptide produced by members of the genus
Pediococcus. The low molecular weight peptide shared amino acid arrangement with N-terminal sequence of Class
IIa, pediocin-like bacteriocins and showed increased activity under reducing conditions. Antimicrobial peptides
active under reduced conditions are valuable for the preservation of processed foods like meat, dairy and canned
foods where low redox potential prevails.
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Bacteria produces different kinds of antimicrobial sub-
stances including ribosomally synthesized bacteriocins
and non-ribosomally synthesized antibiotics or lipopep-
tides as a part of their defense strategies in complex en-
vironments such as fermented foods and the human gut.
Members belonging to the lactic acid bacteria (LAB)
family with ability to produce bacteriocins are frequently
found in these environments [1]. LAB strains are* Correspondence: suresh@imtech.res.in
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croorganisms and have been studied in detail for bio-
technological applications together with the bacteriocins
produced by these strains [2,3]. Members of the genus
Pediococcus are classified within the LAB family and are
reported to produce bacteriocins without post-translational
modifications that are classified under class II bacteriocins
[4,5]. The bacteriocins classified under class IIa are called
as pediocin-like bacteriocins because the first antimicrobial
peptide of this class (pediocin PA-1) was isolated from
Pediococcus sp. [6]. They include variable size peptides
ranging from 2.7 to 4.6 kDa [7–9] with high sequencetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Antimicrobial activity of the cell free fermented
broth (CFB) of 48 h grown culture against various test
strains (mean values of triplicate experiments)
Test strain Inhibition zone
using CFB (mm)
Gram-positive
Listeria monocytogenes (MTCC 839) 13
Lactobacillus plantarum (MTCC 2621) 10
Clostridium bifermentas (MTCC 11273) 10
Clostridium sordelli (MTCC 11072) 12
Bacillus subtilis (MTCC 121) <10
Staphylococcus aureus (MTCC 1430) 10
Micrococcus luteus (MTCC 106) 26
Pediococcus acidilactici (MTCC 7442) -
P. pentosaceus (MTCC 9484) -
P. pentosaceus (MTCC 10308) -
Gram-negative
Vibrio cholera (MTCC 3904) 15
Escherichia coli (MTCC 1610) <10
Pseudomonas aeruginosa (MTCC 1934) 10
Serratia marcescens (MTCC 97) -
Fungi
Candida albicans (MTCC 183) -
Asperigillus flavus (MTCC 8188) -
-, no activity.
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YGNGVXC in their N-terminal domain [10]. However,
bacteriocins lacking the consensus motif are also classified
under pediocin-like bacteriocins [2]. Initially pediocin-like
bacteriocins were reported to be produced by members of
the genus Pediococcus [10] but later were also isolated
from members of other genera like Lactobacillus, Entero-
coccus and Bacillus [11–14]. Since pediocin-like bacterio-
cins are well-known to inhibit the growth of food spoilage
and pathogenic bacteria Listeria monocytogenes, they are
also termed as anti-listerial bacteriocins and considered as
potential antimicrobial additives for food preservation.
Though pediocin producing members of the genus Pedio-
coccus are largely isolated from dairy products, they have
also been reported from diverse environments including
human stool sample [15,16]. However, pediocin-like bacte-
riocins produced by different isolates exhibited 40-60%
similarity in their amino acid sequence [10]. Among the
known variants of pediocin-like bacteriocins, pediocin PA-
1 is well-studied 4.6 kDa antimicrobial peptide with
thermo-stability and wide pH range activity [17]. Never-
theless, it was inactivated by proteases like pepsin, trypsin,
chymotrypsin, proteinase K and pronase E [10]. Further,
structure of the pediocin PA-1 revealed presence of two
β-strands connected by a β-hairpin made up of five
amino acid residues in their N-terminal sequence that
play an important role in antimicrobial activity [18–20].
In this study, we describe the isolation, purification and
characterization of a novel antimicrobial peptide pro-
duced by P. pentosaceus strain IE-3 isolated from a
dairy effluent sample [21].
Results and discussion
Growth conditions and antibacterial activity assay
P. pentosaceus strain IE-3 showed very little growth
while grown in aerobic conditions and optimal growth
was observed under anaerobic conditions. The 48 h cell
free fermented broth (CFB) of P. pentosaceus strain IE-3
grown in anaerobic broth displayed antimicrobial activity
against different indicator strains in well diffusion assay
(Table 1). In contrast to typical narrow spectrum activity
shown by pediocin-like bacteriocins [10], the antimicro-
bial peptide produced by strain IE-3 inhibited growth of
Gram-positive and Gram-negative indicator strains. The
most sensitive strain among the test strains was Micro-
coccus luteus that showed a 26 mm zone of inhibition.
There was no activity observed against other strains of
Pediococcus, yeasts and fungi. A curve displaying anti-
microbial production versus bacterial growth showed that
the antimicrobial peptide production was initiated during
early log phase (6 h of incubation) which increased to a
maximum level by initial stationary phase (14 h) and
remained constant thereafter (Figure 1a). Antimicrobial
activity was obtained when the P. pentosaceus strain IE-3was grown in different media including minimal medium
with optimal production obtained in media like anaerobic
broth, MRS and reinforced clostridial broth, the latter
containing reducing agents (Figure 1b). Significant delay
was observed to reach exponential growth phase by strain
IE-3 while growing in minimal media that resulted in slow
antimicrobial production (data not shown).
Purification of antimicrobial peptide
The crude extract obtained by Diaion HP20 chromatog-
raphy showed significant increase in antimicrobial ac-
tivity compared to CFB. Gel electrophoresis analysis of
this extract displayed a peptide band between 1.7 and
4.5 kDa on tricine SDS-PAGE that showed antimicro-
bial activity against L. monocytogenes in in-gel activity
assay (Figure 2a). Direct detection of antimicrobial ac-
tivity by in-gel activity assay revealed that the inhibition
was caused by a low molecular weight (LMW) peptide.
The extract was purified on a cation exchange column
and the active fraction obtained was used for gel filtra-
tion chromatography analysis that anticipated the mo-
lecular mass to be in the range of 2.0 - 5.5 kDa
(Figure 2b). The purified peptide showed a single peak
in reversed phase HPLC with absorbance between 260–
280 nm (Figure 2c) that may be due to the presence of
Figure 1 Antimicrobial production by P. pentosaceus strain IE-3. (a) Correlation between antimicrobial peptide production and growth of
strain IE-3. Growth measured as OD at 600 nm (dotted lines), bacteriocin production as zone of inhibition (continuous line). Error bars shows ± SD
for triplicate experiments. Culture was grown in anaerobic broth under anaerobic conditions at 30°C on a shaker incubator. (b) Antimicrobial assay
of 24 h cell free fermented broth obtained by growing strain IE-3 on different media.
Figure 2 Characterization of low molecular weight antimicrobial peptide produced by P. pentosaceus strain IE-3. (a) In-gel activity assay
of crude extract on 18% tricine SDS-PAGE gel, lane 1 contains low molecular weight protein marker, lane 2 crude extract obtained from Diaion
HP20 and lane 3 showing antimicrobial activity against L. monocytogenes MTCC 839 (b) Size determination by gel filtration chromatography of
cation exchange purified peptide along with standard graph (of known molecular weight proteins depicts low molecular size). (c) Reverse-phase
HPLC profile of purified antimicrobial peptide and inset showing the absorbance between 260–280 nm. (d) Intact molecular mass showing as
1701.00 Da in MALDI-TOF analysis.
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age of the purified peptide at room temperature signifi-
cant reduction in antimicrobial activity was observed
within 24 h, but was stable when stored at −20°C. Sub-
sequently, it was found that the loss of antimicrobial
activity was due to oxidation of peptide as observed for
pediocin-like bacteriocins [22].
Molecular mass analysis and de novo sequencing of LMW
peptide
The molecular mass for LMW antimicrobial peptide was
determined as 1701.00 Da (Figure 2d) by MALDI-TOF MS.
The primary structure of the peptide by MS/MS sequen-
cing revealed the sequence as APVPFSCTRGCLTHLV with
high score value of 47.59 (Figure 3). The mass obtained in
MALDI-TOF is in agreement with the estimated theoretical
average mass (1701.03 Da) obtained for the sequence.
Minor differences in mass may be due to the instrument
error which deviates up to 50 ppm. Further, bioinformatics
analysis of the sequence did not show any significant simi-
larity with known pediocin-like bacteriocins or other bac-
terial AMPs available with databases like Bactibase [23,24]
or Collection of Antimicrobial Peptide (CAMP) database
[25]. In fact, the de novo sequence was used for blast ana-
lysis against the published genome of strain IE-3, but couldFigure 3 De novo sequence derived for the antimicrobial peptide gen
(b ion values shown at bottom and y ion values at top).not find any significant blast hit covering the entire peptide
sequence in the annotated proteins. Further, genome se-
quence analysis to find the ORF coding this peptide did
not show any significant similarity. In this regard, it is
pertinent to note that the genome of IE-3 is a draft ver-
sion, hence, putative region encoding the small peptide
may have missed in the draft genome due to gaps
formed during the assembly of raw sequence data (as
contig cutoff size of ≥500 nucleotides was used). Con-
sidering ambiguities in de novo sequencing, search was
also made by replacing Leu residue with Ile as well as
other de novo sequences obtained with low score values,
however, no ORF was found in genome sequence. As no
ORF detected in genome, it is anticipated that antimicro-
bial peptide might be produced from medium compo-
nents by the strain IE-3. Nevertheless, synthesis of peptide
from the medium components is ruled out as the peptide
production was observed in minimal medium containing
an inorganic nitrogen source. Though the de novo se-
quence similarity search using APD2 [26] revealed low
similarity (37% similarity) with the eukaryotic antimicro-
bial peptide, temporin LTb, it did not show any conserved
motifs observed for temporins [27]. Antimicrobial peptide
prediction analysis [26] of the de novo sequence suggested
that the peptide could be a potential antimicrobial peptideerated by de-novo explorer of AB Sciex with highest score value
Table 2 Influence of different pH values and DTT
concentrations on antimicrobial activity of the LMW
peptide produced by P. pentosaceus strain IE-3
Treatments Reaction condition Residual activity (%)
pH
2 Overnight/ RT 100.0
3 Overnight/ RT 100.0
4 Overnight/ RT 100.0
5 Overnight/ RT 100.0
6 Overnight/ RT 87.5
7 Overnight/ RT 75.0
8 Overnight/ RT 37.5
9 Overnight/ RT 25.0
10 Overnight/ RT 12.5
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amino acids, along with two cysteine residues. Moreover,
this LMW peptide shares an amino acid arrangement with
N-terminal sequence of other pediocin-like bacteriocins
such as pediocin PA-1 [9,28]. Remarkably, the five amino
acids (CTRGC) of the peptide showed amino acids pat-
tern similarity with β-hairpin composition (CTKSGC)
of pediocin-like bacteriocins [29] where the positively
charged amino acid play crucial role in antimicrobial ac-
tivity [10]. In fact, addition of a positively charged amino
acid within this patch showed significant increase in anti-
microbial activity of pediocin PA-1 [30]. Additionally,
structure prediction analysis for the LMW peptide showed
antiparallel β-sheet confirmation (Figure 4) where hydro-
phobic and positively charged amino acids are enclosed by
two cysteine residues (Cyt7-Cyt11).DTT concentration
0 mM 1 h/RT 100.0
50 mM 1 h/RT 125.0
100 mM 1 h/RT 143.7
150 mM 1 h/RT 143.7
RT, room temperature.Effect of pH, temperature, proteolytic enzymes, reducing
agent and H2O2 on antimicrobial activity
The LMW antimicrobial peptide was found to be
thermo-stable as there was no reduction observed in its
antimicrobial activity even after 30 min of incubation at
100°C. However, it displayed sensitivity towards the pH
as the maximum activity was observed at pH 5 and sig-
nificant loss was found at pH 8 and above (Table 2). Un-
like pediocin-like bacteriocins, the low molecular weight
peptide in this study was found to be resistant to proteo-
lytic cleavage as an antimicrobial assay performed upon
incubation with proteolytic enzymes showed no reduc-
tion in activity. Stable activity upon treatment with
amylase revealed the absence of any sugar moiety associ-
ated with inhibition activity of the bacteriocin. Interestingly,
the peptide showed significant increase in antimicrobial
activity when it was tested upon incubation with DTT
(Figure 5a). The increase in activity was observed with
the increase in DTT concentration up to 150 mM
(Table 2). However, peptide incubated with H2O2 did
not show any antimicrobial activity confirming the in-
activation of LMW peptide upon oxidation. Results ofFigure 4 Predicted 3-dimensional structure of de novo
sequence obtained for low molecular weight antimicrobial
peptide showing the presence of antiparallel β-sheets.control DTT experiments showed no effect on the
growth of indicator strains.Determination of minimum inhibitory concentration of
the LMW peptide
Determination of minimum inhibitory concentration (MIC)
for various indicator organisms revealed that the peptide
was most active against M. luteus of Gram-positive strains
with an MIC value of 6.3 μM. Among the Gram-negative
strains,V. cholera growth was inhibited at 25.4 μM concen-
tration. The MIC values observed for the peptide were
higher when compared to other pediocin-like bacteriocins,
however, MIC determined for peptide treated with DTT
were found to be significantly lower than the native peptide
(Figure 5b). Again, M. luteus, L. monocytogenes and V. chol-
era were observed as the most sensitive, however, test
strains like B. subtilis and E. coli were inhibited more effi-
ciently with the DTT treated peptide compared to native
peptide. Hemolysis of rabbit RBCs was not observed at con-
centrations up to 100 μM of peptide.Conclusions
Although production of LMW antimicrobial peptides
from different bacteria was reported in the literature, no
peptide of less than 2.5 kDa was reported from Pediococ-
cus species. Pediocin-like bacteriocins are produced by
the pediocin biosynthetic gene cluster pedABCD that are
highly conserved among Pediococcus strains, however,
strains like P. acidilactici did not produce any antimicro-
bial substance though it contained pediocin biosynthetic
Figure 5 Antimicrobial activity assay of native and DTT (100 mM) treated LMW peptides against Gram-positive and Gram-negative
(I, B. subtilis; II, L. monocytogenes; III, E. coli; IV, P. aeruginosa and V, V. cholera) indicator strains (a). Comparison of MIC values against
various test strains (b). Standard deviation (SD) is shown as error bars; significant difference between DTT treatment and control with p < 0.05
was observed in two independent experiments performed in triplicates.
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strain IE-3 in this study showed presence of pediocin
biosynthetic gene cluster pedABCD but did not produce
any pediocin-like bacteriocin. We conclude that P. pen-
tosaceus strain IE-3 produces a LMW antimicrobial pep-
tide with broad spectrum antimicrobial activity that is
resistant to proteases. Therefore, it may be used effectively
against food spoilage bacteria and developed as an effi-
cient preservative for processed foods in food industry.
Methods
Bacterial strains and growth media
The antimicrobial producing bacterial strain IE-3 was
isolated from a dairy industry effluent sample. The draft
genome sequence of strain IE-3 has been published earl-
ier [21]. All test strains used in the present study were
obtained from Microbial Type Culture Collection and
Gene Bank (MTCC and Gene Bank), CSIR-Institute of
Microbial Technology, Chandigarh, India. Indicator strains
like, Bacillus subtilis MTCC 121, Staphylococcus aureus
MTCC 1430, Micrococcus luteus MTCC 106 Pseudomonas
aeruginosa MTCC 1934, and Escherichia coli MTCC 1610
were grown on nutrient agar (M001, Himedia, India),Vibrio cholerae MTCC 3904 was on LB medium (M1151,
Himedia, India). Brain heart infusion agar (M1611, Hime-
dia, India) was used to cultivate Listeria monocytogenes
MTCC 839 and MRS medium (M641, Himedia, India) for
Lactobacillus plantarum MTCC 2621. Clostridium bifer-
mentans MTCC 11273, C. sordelli MTCC 11072, Pediococ-
cus acidilactici MTCC 7442, P. pentosaceus MTCC 3817
and P. pentosaceus MTCC 9484 were grown on anaerobic
agar (M228, Himedia, India). Among the eukaryotic test
strains while Candida albicans MTCC 1637 was grown on
YEPD medium (G038, Himedia, India), Czapek yeast
extract agar (M1335, Himedia, India) was used to culti-
vate Aspergillus flavus MTCC8188. To test the influ-
ence of growth medium on antimicrobial production
strain IE-3 was grown on nutrient broth (M002, Himedia,
India), tryptone soya broth (LQ508, Himedia, India), rein-
forced clostridial broth (M443, Himedia, India), MRS broth
(M369, Himedia, India) and minimal medium. Compos-
ition of anaerobic broth used for bacteriocin production
contains (per liter) casein enzymic hydrolysate, 20.0 g; dex-
trose, 10.0 g; sodium chloride, 5.0 g; sodium thioglycollate,
2.0 g; sodium formaldehyde sulphoxylate 1.0 g; methylene
blue, 0.002 g and pH adjusted to 7.2 ± 0.2. The minimal
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2SO4, 0.5 g; MgSO4. 7H2O, 0.1 g; FeSO4.7H2O, 0.02 g;
trace element solution 1 ml; NaNO3, 0.45 mg; L-Cysteine
HCl, 50 mg supplemented with 1% of dextrose or 0.05% of
peptone or yeast extract. The dextrose solution was steril-
ized separately and added to the minimal medium after
autoclave under aseptic conditions. All above media were
prepared anaerobically (by purging with oxygen free nitro-
gen while boiling the medium) in serum vials and sealed
under anaerobic conditions. Inoculation and sampling was
done by using sterile syringes.Bacteriocin activity assay
For antimicrobial peptide production strain IE-3 was
grown in anaerobic broth for 48 h under anaerobic con-
ditions using nitrogen gas. The culture was incubated at
30°C with shaking at 120 rpm for optimal growth. The
CFB obtained by removing the cells present in the
medium by centrifugation (6,000 g for 10 min, 4°C) and
subsequent filtration of the supernatant through 0.22 μm
filter (Millipore, USA). The CFB was used to test the
growth inhibition activity by agar well diffusion assay
using actively growing test strains (between 0.2-0.4 OD).
A growth curve verses antimicrobial production graph up
to 48 h was constructed for strain IE-3 to examine the
bacteriocin production at regular time intervals using an-
aerobic broth. Bacterial growth was measured as absorb-
ance at 600 nm after constant time intervals of 2 h and
antimicrobial activity at same time point was estimated by
zone inhibition assay against L. monocytogenes test strain.Purification of low molecular weight antimicrobial peptide
Strain IE-3 was grown anaerobically in serum vials at 30°C
for 48 h for the maximum production of a LMW peptide.
Antimicrobial compound was extracted from CFB using
2% activated Diaion HP20 (Sigma, USA) hydrophobic
resin. The crude extract obtained was further purified
through cation exchange (Capto S, GE Healthcare, USA)
chromatography column linked to an AKTA prime plus
(GE healthcare, USA), in 20 mM sodium acetate buffer
(pH 4.6) and eluted with NaCl gradient (50 to 1000 mM)
in binding buffer. The peptide was desalted using dialy-
sis tube (molecular cutoff 0.5 kDa, Spectrum, USA).
Approximate molecular mass of peptide was deter-
mined by gel filtration column (Sodex KW-802.5) using
standard molecular weight markers as described earlier
[31]. Purity was confirmed by reversed phase HPLC
(10 mm × 250 mm × 150 Å) C-18 column (venusil,
Agela Technologies) under isocratic flow (1.5 ml/min)
of acetonitrile (20%) along with 0.1% TFA. Elution was
monitored at 200–340 nm wavelength range on PDA
detector and peaks were collected by fraction collector
(1260 Infinity, Agilent technology, USA).In-gel activity assay
The partially purified antimicrobial peptide (50 μg/lane)
was electrophoresed in duplicate on 18.0% tricine SDS-
PAGE [32]. One set of the gel lane along with protein
ladder (multi-color low range protein ladder, Thermo
Spectra™) was stained with Coomassie brilliant blue to
confirm the location of the antimicrobial peptide and
the other lane of the gel was used to test antimicrobial
activity as described earlier [33] by overlaying with 5 ml
of log-phase culture of L. monocytogenes (106 cells/ml)
and was incubated at 30°C overnight.
Intact mass analysis and de novo sequencing
To analyze the molecular mass of peptide, purified pep-
tide was electrophoresed, eluted from tricine SDS-PAGE
by 75% acetonitrile with 0.1% TFA and used only for
mass analysis and sequencing. Eluted peptide was mixed
with equal ratios (1:1) of α-cyano-4-hydroxycinnamic
acid in 50% acetonitrile and 0.1% (v/v) TFA. Samples
were air dried and analyzed on an AB Sciex 5800
MALDI-TOF-TOF™ mass spectrometer. MS/MS data
was acquired at 1000 Hz in 1 kV MSMS mode with
2000 laser shots/spectrum in CID (collision induced dis-
sociation) mode to obtain maximum resolution. Se-
quence was generated by de novo explorer of AB Sciex
and the highest score value sequence was considered as
putative sequence. Further, structure was predicted on
PEP-FOLD [34] server using de novo sequence. The
structure obtained was visualized in PyMOL [35].
Determination of minimum inhibitory concentration (MIC)
The MIC was determined for various indicator strains
using a microtiter plate dilution assay as described earl-
ier [31]. Cell growth was measured by observing OD at
600 nm at 16 h time interval using microtiter plate
reader (Multiskan spectrum, Thermo, USA). The protein
concentration was determined by BCA protein concen-
tration estimation kit (Thermo, USA) following instruc-
tions of the manufacturer. For MIC determination of
DTT treated peptide, the DTT solution was filter steril-
ized and final 100 mM concentration was used to treat
peptide.
Effect of pH, temperature, proteolytic enzymes, DTT and
H2O2 on bacteriocin activity
The sensitivity of the bacteriocin towards different pH,
temperatures and proteases was evaluated using purified
bacteriocin. The purified peptide was incubated between
pH values 2.0-10.0 and temperatures including 80, 100°C
for 30 min and 120°C for 15 min. Antimicrobial peptide
(200 μg) was incubated with various proteolytic enzymes
such as trypsin (10 μg/ml, Sigma, USA), chymotrypsin
(5 μg/ml, Sigma, USA) and proteinase K (5 units, Sigma,
USA) in 100 mM Tris HCl buffer pH 8.0 (with 10 mM
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zyme activity was terminated by heating the reaction
mix at 80°C and subsequently used for antimicrobial ac-
tivity assay. To test the effect of denaturant like DTT
(BioRad, USA) on antimicrobial activity of the peptide,
it was incubated with 50 to 150 mM DTT at room
temperature for 1 h and used for growth inhibition
assay. Hydrogen peroxide induced oxidation was tested
by incubating the purified peptide with 100 mM con-
centration of hydrogen peroxide (Merck, India) for 1 h
at room temperature [36] and activity was tested by
well diffusion assay.
Hemolysis assay
Blood was collected from New Zealand white rabbit,
housed under normal conditions and had free access to
a standard diet and water in Animal facility of the Insti-
tute. All animal protocols were followed according to
the National Regulatory Guidelines issued by Committee
for the Purpose of Control and Supervision of Experi-
ments on Animals (CPCSEA), Ministry of Environment
& Forests (Government of India). Red blood cells (RBCs)
were separated from the whole blood by centrifugation
(900 g) and washed twice with phosphate buffer saline
(PBS). Washed cells resuspended into PBS and were
counted using heamocytometer. For heamolysis, 2×108
cells/ml were used as mentioned [37]. They were treated
with different concentrations of purified peptide (ranging
from 5 to 100 μM) and incubated in CO2 incubator for
24 h at 37°C. After incubation, cell free supernatant was
separated by centrifugation (900 g) and absorbance was
taken at 541 nm. PBS and triton X100 (0.1% v/v) were
used as baseline and 100% lysis controls, respectively.
Statistical analysis
Statistical significance of experimental results was deter-
mined by Student’s t test analysis and values of p < 0.05
were considered statistically significant. Data obtained
from two individual experiments performed in triplicates
was used.
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